Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
Feb. 29, 2020
Nov. 30, 2019
CURRENT    
Cash $ 299,751 $ 1,081,900
Restricted cash 92,000 92,000
Accounts receivable 92,221 438,255
Inventory, net 1,377,140 959,748
Total Current Assets 2,262,976 2,949,208
Patent rights, net 859,583 99,002
Deposits for equipment 217,811 196,921
Right-of-use asset 58,196  
Property and equipment, net 322,932 321,288
TOTAL ASSETS 3,721,498 3,566,419
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 987,374 650,719
Convertible notes payable, net 3,101,727 2,758,578
Accrued interest 301,071 266,143
Total Current Liabilities 4,390,172 3,675,440
Long-term convertible notes payable 2,029,947 1,874,972
Operating lease liabilities, noncurrent 29,403  
Total Liabilities 6,449,522 5,550,412
Commitments
Capital stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil shares issued and outstanding (2019: Nil).
Common stock, $0.001 par value 300,000,000 shares authorized, 104,813,647 shares issued and outstanding (2019: 300,000,000 shares authorized, 104,021,836 shares issued and outstanding) 104,814 104,022
Additional paid-in capital 37,168,666 36,480,520
Shares to be issued 20,000 20,000
Treasury stock receivable, Nil shares (2019: 3,699,999 shares)   (888,000)
Accumulated deficit (39,946,496) (37,662,123)
Accumulated other comprehensive loss (75,008) (38,412)
Total Stockholders' Deficit (2,728,024) (1,983,993)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 3,721,498 $ 3,566,419